Tag: Portable Oxygen Concentrators

LONDON and PLANO, Texas – Belluscura has entered into an agreement to supply portable oxygen concentrators to VGM Group members. “Our partnership with VGM enables us to work together to provide access to our next generation portable oxygen concentrators,” said Robert Rauker, CEO of Belluscura. “The partnership provides a further opportunity to support the group's continued growth. We look forward to working with VGM in expanding access to our high performing, lighter oxygen...

GOLETA, Calif. – Supply chain challenges, as well as a temporary shutdown at facilities in Texas and California earlier this year, forced Inogen to prioritize available supply in the first quarter of 2022 to its domestic direct-to-consumer and rental channels, contributing to an 83.4% drop in revenues for its business-to-business channel.  “As of early May, we have started shipments to our domestic B2B channel in order to alleviate some of the backlog in our system,”...

LONDON and PLANO, Texas – Belluscura has named Brian Brown as vice president of engineering. Brown has more than 25 years of experience in commercializing new products in hardware, software and service delivery industries. His past roles include building a startup firm into a world leading supplier of diagnostic imaging medical devices, holding the titles of president and chief innovation officer. “We look forward to leveraging Brian’s background in new product commercialization,”...

LONDON – Belluscura has signed a three-year manufacturing agreement for its X-PLO2r portable oxygen concentrator with InnoMax Medical Technology in China. “Manufacturing X-PLO2R products at the national innovation center for medical devices with an affiliate of the world’s leading electronics manufacturing company is transformational,” said Robert Rauker, CEO of Belluscura. “The agreement will more than double our manufacturing capacity and will provide access to the...

BALL GROUND, Ga. – CAIRE’s FreeStyle Comfort portable oxygen concentrator outperformed other market leading devices in a recent study designed to assess the effectiveness of these devices in delivering oxygen to patients. “Portable oxygen concentrators are intended to allow patients to maintain a more active lifestyle despite the constraints which COPD or other respiratory conditions might introduce,” said Barry hassett, vice president of global marketing. “The FreeStyle...

GOLETA, Calif. – Inogen expensed $2.3 million in higher material costs in the fourth quarter of 2021 and expects that number to double in the first quarter of 2022, company officials say.  Inogen expects $4.5 million to $5.5 million in incrementally higher material costs in the first quarter of 2022 associated with open market purchases of semiconductor chips used in its batteries and portable oxygen concentrators, says interim CFO Mike Sergesketter.  “We expect this cost...

GOLETA, Calif. – Inogen says its revenues are expected to increase for the fourth quarter of 2021, but a chip shortage has forced the company to temporarily suspend manufacturing operations at its Texas and California locations.  Inogen doesn’t expect to furlough any employees as a result of the suspension, as the company currently anticipates restarting manufacturing at all locations around mid- to late February 2022 based on the information available to date.  For the...

GOLETA, Calif. – Demand is high, but with supply restricted, Inogen is prioritizing POC orders from its direct-to-consumer channel.  That meant it was unable to fulfill some orders from other channels, particularly its domestic business-to-business channel, which saw sales of $22.8 million in the third quarter, down 1.1% from the same period last year.  "Due to supply chain constraints and in an effort to optimize financial results, we intentionally focused our available capacity...

GOLETA, Cailf. – Inogen has announced an agreement with Ashfield Healthcare to enhance its go-to-market capabilities.  Per the agreement, Ashfield will add about 20 dedicated sales representatives to Inogen’s prescriber sales organization and provide the company access to its proprietary insights and data, including the specialized health care intelligence platform Gravity.ai, to support growth and drive performance in the clinician sales channel.  “Forming this...

SAN DIEGO – ResMed incurred a $13.9 million restructuring expense in the second quarter of its fiscal year 2021 as a result of closing its portable oxygen concentrator business.  The company stopped selling its Mobi POCs in November.  “Going forward, the cessation of the POC business will have an immaterial impact on both group revenue and earnings per share,” said Brett Sandercock, CFO, during a conference call on...